Toronto Stocks Inch Down; AGF Management Falls on Lower 3Q Earnings
By Adriano Marchese
Toronto stocks were edging lower midday Wednesday. Sector performance was mixed in the session, with gains logged primarily in the materials, retail and utilities sectors. The main laggards were in manufacturing, energy and consumer durables stocks.
Canada's S&P/TSX Composite Index was 0.1% lower at 23938.46. The blue-chip S&P/TSX 60 remained virtually unchanged at 1434.76.
AGF Management shares fell 4% to 8.26 Canadian dollars ($6.15) after it reported lower earnings in the third quarter. The asset manager noted that it has seen early signs of improvement with positive retail net flows and a solid investment performance.
Other market movers:
Dye & Durham's minority activist investor Engine Capital said it will withdraw a request for a special shareholder meeting if the company schedules its annual general meeting in December, as per usual. Engine Capital noted, however, that it will still seek board changes at that meeting. Shares fell 1.8% to C$15.82.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
September 25, 2024 12:14 ET (16:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks